Extra-cochlear implanted hearing aid device
View Patent ↗An extra-cochlear hearing aid implant is characterized by a pad having a plurality of electrode prongs that extend therefrom and which are adapted to provide an electrical stimulus to hearing cells within the cochlea. The electrode pad is adapted to be placed onto endosteum overlying the cochlea in an “extended soft surgery” technique. The prongs are configured to pierce the endosteum and extend into the cochlea. In one form, the extra-cochlear hearing aid implant also includes hollow tubules that extend from the pad and which are adapted to supply and withdraw neurotrophic proteins and other materials in a fluid into and from the cochlea, and also to provide electrical stimulus to the hearing cells.
1. An extra-cochlear hearing aid implant comprising:
a pad configured to overlie an endosteum of a cochlea; and
a plurality of electrodes extending from an underside of the pad and configured to pierce the endosteum of the cochlea and extend into an interior of the cochlea, the plurality of electrodes providing a plurality of different sound simulating electrical stimuli to at least one of a plurality of dendrites and plurality of spiral ganglia within the interior of the cochlea to foster hearing; and
wherein the pad is sized for placement on the endosteum of the cochlea and the pad, and plurality of electrodes, are sized and configured for subcutaneous implantation.
2. The extra-cochlear hearing aid implant of claim 1 , wherein each of the plurality of electrodes is adapted to provide an electrical stimulus, and wherein the pad includes a plurality of electrical traces corresponding to the plurality of electrodes, the plurality of traces adapted to be connected to a source of electrical stimulus.
3. The extra-cochlear hearing aid implant of claim 2 , further comprising a connector carried on the pad and electrically coupling the plurality of electrical traces with an electrically conductive wire.
4. The extra-cochlear hearing aid implant of claim 1 , wherein the plurality of electrodes are variable in length.
5. The extra-cochlear hearing aid implant of claim 1 , further comprising a fluid exchange system carried on the pad for supplying and withdrawing fluid to and from the an inside portion of the cochlea for improving at least one of the health and sound processing capabilities of the cochlea.
6. The extra-cochlear hearing aid implant of claim 1 wherein the plurality of electrodes have at least one of a generally cylindrical shape and a generally tapering shape.
7. The extra-cochlear hearing aid implant of claim 1 , wherein the plurality of electrodes are needle-like, and are of sufficient strength to resist deformation upon piercing at least one of an endosteum and a modiolus bone.
8. The extra-cochlear implant of claim 1 wherein substantially all of the plurality of electrodes each includes an insulating covering extending over a portion of the electrode.
9. The extra-cochlear hearing aid implant of claim 8 wherein the electrodes include a base portion affixed to the pad, a tip portion placeable inside the cochlea, and a middle portion extending between the base portion and the tip portion, wherein the covering covers the base and the middle portions to facilitate the discharge of an electrical stimulus only at the tip portion.
10. The extra-cochlear implant of claim 9 wherein the covering comprises a coating applied to the base and middle portion of the electrode.
11. The extra-cochlear implant of claim 1 wherein the electrodes comprises an electrode selected from the group consisting of nanotubules, nanowires, and nanocable electrodes.
12. An extra-cochlear hearing aid implant comprising
a pad configured to subcutaneously overlie a portion of a cochlea;
a plurality of electrodes extending from an underside of the pad for providing a plurality of different sound simulating electrical stimuli to at least one of a plurality of dendrites and plurality of spiral ganglia and configured to pierce and extend into an interior of the cochlea, and
a fluid exchange system carried on the pad for supplying withdrawing fluid to and from the interior of the cocklea for improving at least one of the health and sound processing capabilities of the cochlea.
13. The extra-cochlear hearing aid implant of claim 12 , wherein the fluid exchange system comprises a hollow supply tube extending from the underside of the pad and configured to pierce and extend through an endosteum and into the cochlea, and a hollow withdrawal tube extending from the underside of the pad and configured to pierce and extend through the endosteum and into the cochlea.
14. The extra-cochlear hearing aid implant of claim 12 , wherein the fluid exchange system comprises a plurality of hollow supply tubes extending from the underside of the pad and configured to pierce and extend into the cochlea, and a hollow withdrawal tube extending from the underside of the pad and configured to pierce and extend into the cochlea.
15. The extra-cochlear hearing aid implant of claim 12 , wherein the pad includes a plurality of electrical traces corresponding to the plurality of electrodes, the plurality of traces adapted to be connected to a source of electrical stimulus.
16. The extra-cochlear hearing aid implant of claim 15 , further comprising a connector carried on the pad and electrically coupling the plurality of electrical traces with an electrical wire.
17. The extra-cochlear hearing aid implant of claim 12 , wherein the plurality of electrodes are variable in length.
18. The extra-cochlear hearing aid implant of claim 12 , wherein the plurality of electrodes have a generally tapering shape.
19. The extra-cochlear heaving aid implant of claim 12 wherein the plurality of electrodes have a generally cylindrical shape, and are of sufficient strength to resist deformation upon piercing at least one of an endosteum and a modiolar bone.
20. The extra-cochlear hearing aid implant of claim 12 wherein the fluid exchange system supplies and withdraws neurotrophic material selected from the group consisting of neurotrophins, neuroptropins, antioxidants, vasoactive compounds, growth factors, antibiotics, antiglycemics, insulin, medications, nucleotides, amino acids, nutrients, cells, stem cells, and nanobots.
21. The system of claim 12 , further comprising a fluid supply pump with a self-sealing detachable outlet valve and a bacterial filter.
22. The system of claim 12 , wherein the fluid exchange system comprises a combined fluid and electrical system including at least two tubes, whereby the tubes conduct electrical stimuli into the cochlea in addition to acting as fluid conduits.
23. The extra-cochlear hearing aid of claim 12 wherein the supplied and withdrawn fluid comprises a neurotrophic fluid that comprises a slow release compound containing an active ingredient selected from the group consisting of neurotrophins, neurotropins, antioxidants, vasoactive compounds, growth factors, antibiotics, anti-glycemics, insulin, medications, nucleotides, amino acids, nutrients, cells, stem cells, nano-robots, and nanobots.
24. The extra-cochlear hearing aid of claim 23 wherein the slow release compound is attached to the electrodes.
25. The extra-cochlear hearing aid of claim 23 , wherein the fluid exchange system includes at least one hollow supply tube extending from the underside of the pad and configured to pierce an endosteum of the cochlea and extend into the cochlea, and
wherein the slow release compound is attached to at least one of the electrodes and tube.
26. The extra-cochlear hearing aid of claim 25 wherein the slow release compound is disposed on at least one of the electrode and tube for preventing debris from blocking the tube.
27. The extra-cochlear hearing aid of claim 23 , wherein the slow release compound is selected from the group consisting of pastes, coatings, bonded materials, fillings, shaped deposit and nano-containers.